Forbes Magazine

See the following -

4 Reasons U.S. EMR Firms Won’t Try China

James Ritchie | EMR & HIPAA | October 23, 2013

If you have something to sell, chances are you’ve thought about selling it in China. Read More »

EHR Systems & Cost Transparency in the Healthcare Industry

Cost transparency is obviously a big issue in the healthcare industry. Whether it’s the amazing variation in costs hospitals charge patients for similar medical procedures, or the costs associated with acquiring and implementing an Electronic Health Record (EHR) system for a hospital - Why are all these costs often carefully hidden?  Is there something special about the healthcare industry that says – "Let's not talk about how much things really cost." Apparently, many industry leaders must feel that hospitals boards and patients have no need to know this information. Read More »

Soaring Clinical Trials Costs And Effects On Drug Prices

Ryan Haake | PharmaThought | August 5, 2014

The cost to bring a new drug to market has skyrocketed over the past several decades and, in large part, is due to the rising cost of clinical trials. In 2013, Forbes magazine estimated it would cost a company over $350 million for one drug to reach patients...

Read More »